Literature DB >> 19357955

Management of brain metastases: the indispensable role of surgery.

George Al-Shamy1, Raymond Sawaya.   

Abstract

Brain metastases are the most common neurological complication of systemic cancer and carry a very poor prognosis. The management of patients with brain metastases has become more important recently because of the increased incidence of these tumors and the prolonged patient survival times that have accompanied increased control of systemic cancer. In this article, we review the current perspectives on surgical treatment of brain metastases in terms of patient selection criteria, intraoperative adjuncts, whole-brain radiation therapy (WBRT) as a postoperative adjuvant, reoperation for tumor recurrence, and resection of multiple and single metastases. Achieving the best outcome in treatment of brain metastasis requires the judicious and complementary use of surgical resection along with modalities such as whole-brain radiation therapy and stereotactic radiosurgery.

Entities:  

Mesh:

Year:  2009        PMID: 19357955     DOI: 10.1007/s11060-009-9839-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  53 in total

Review 1.  Surgical treatment of brain metastases.

Authors:  R Sawaya
Journal:  Clin Neurosurg       Date:  1999

Review 2.  Brain metastases.

Authors:  Mark E Shaffrey; Melike Mut; Anthony L Asher; Stuart H Burri; Ali Chahlavi; Susan M Chang; Elana Farace; John B Fiveash; Frederick F Lang; M Beatriz S Lopes; James M Markert; David Schiff; Vitaly Siomin; Stephen B Tatter; Michael A Vogelbaum
Journal:  Curr Probl Surg       Date:  2004-08       Impact factor: 1.909

3.  Part II: Surgery versus radiosurgery for brain metastasis: surgical advantages and radiosurgical myths.

Authors:  Amos O Dare; Raymond Sawaya
Journal:  Clin Neurosurg       Date:  2004

4.  The treatment of patients with recurrent brain metastases. A retrospective analysis of 109 patients with nonsmall cell lung cancer.

Authors:  E Arbit; M Wroński; M Burt; J H Galicich
Journal:  Cancer       Date:  1995-09-01       Impact factor: 6.860

5.  Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.

Authors:  Andreas M Stark; Hauke Tscheslog; Ralf Buhl; Janka Held-Feindt; H Maximilian Mehdorn
Journal:  Neurosurg Rev       Date:  2004-12-18       Impact factor: 3.042

Review 6.  Demographics of brain metastasis.

Authors:  J D Johnson; B Young
Journal:  Neurosurg Clin N Am       Date:  1996-07       Impact factor: 2.509

7.  Surgery versus radiosurgery in the treatment of brain metastasis.

Authors:  A K Bindal; R K Bindal; K R Hess; A Shiu; S J Hassenbusch; W M Shi; R Sawaya
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

8.  Brain metastases in patients with renal cell carcinoma: prognosis and treatment.

Authors:  D A Decker; V L Decker; A Herskovic; G D Cummings
Journal:  J Clin Oncol       Date:  1984-03       Impact factor: 44.544

9.  Surgical treatment of single brain metastasis: factors associated with survival.

Authors:  J H Galicich; N Sundaresan; E Arbit; S Passe
Journal:  Cancer       Date:  1980-01-15       Impact factor: 6.860

10.  Defining the role of radiosurgery in the management of brain metastases.

Authors:  M P Mehta; J M Rozental; A B Levin; T R Mackie; S S Kubsad; M A Gehring; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

View more
  51 in total

Review 1.  Neurosurgical management of metastases in the central nervous system.

Authors:  Elizabeth B Claus
Journal:  Nat Rev Clin Oncol       Date:  2011-12-06       Impact factor: 66.675

Review 2.  Management of brain metastasis: past lessons, modern management, and future considerations.

Authors:  Eugene Koay; Erik P Sulman
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

3.  Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literature.

Authors:  Concetta Elisa Onesti; Daniela Iacono; Silvia Angelini; Salvatore Lauro; Marco Mazzotta; Mario Alberto Occhipinti; Raffaele Giusti; Paolo Marchetti
Journal:  Transl Lung Cancer Res       Date:  2016-12

Review 4.  Are immune checkpoint blockade monoclonal antibodies active against CNS metastases from NSCLC?-current evidence and future perspectives.

Authors:  Grainne M O'Kane; Natasha B Leighl
Journal:  Transl Lung Cancer Res       Date:  2016-12

5.  Operative treatment of subcortical metastatic tumours in the central region.

Authors:  J Walter; S A Kuhn; A Waschke; R Kalff; C Ewald
Journal:  J Neurooncol       Date:  2010-09-29       Impact factor: 4.130

Review 6.  Systemic Therapy of Lung Cancer CNS Metastases Using Molecularly Targeted Agents and Immune Checkpoint Inhibitors.

Authors:  Grainne M O'Kane; Natasha B Leighl
Journal:  CNS Drugs       Date:  2018-06       Impact factor: 5.749

7.  Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

Authors:  Mihaela Lorger; Brunhilde Felding-Habermann
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

8.  Comparison of in vitro and in vivo approaches to studying brain colonization by breast cancer cells.

Authors:  M Lorger; H Lee; J S Forsyth; B Felding-Habermann
Journal:  J Neurooncol       Date:  2011-02-27       Impact factor: 4.130

9.  Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.

Authors:  A Ali; J R Goffin; A Arnold; P M Ellis
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

10.  Surgical outcome of patients considered to have "inoperable" tumors by specialized pediatric neuro-oncological multidisciplinary teams.

Authors:  Charles Teo; Teo Charles; Morgan Broggi; Broggi Morgan
Journal:  Childs Nerv Syst       Date:  2010-06-19       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.